Back
ESC Premium Access

Association of glycated haemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE consortium

Session: Risk Factors and Prevention ePosters
Topic: Diabetes and the Heart
Speaker: Assistant Professor C. Sinning (Hamburg, DE)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Assistant Professor Christoph Sinning

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
5 presentations
0 follower

224 more presentations in this session

High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events

Speaker: Doctor B. Keskin (Istanbul, TR)

Access
Abstract
Slides
0
Thumbnail

Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines

Speaker: Doctor R. Ong (Makati, PH)

Access
Abstract
Slides
0
Thumbnail

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project

Speaker: Doctor A. Bendary (Benha, EG)

Access
Abstract
Slides
0
Thumbnail

SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization

Speaker: Mr R. Gascuena (Leganes, ES)

Access
Abstract
Slides
0
Thumbnail

Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome

Speaker: Doctor S. Vohra (Lucknow, IN)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Risk Factors and Prevention ePosters

Speakers: Assistant Professor C. Sinning, Doctor B. Keskin, Doctor R. Ong, Doctor A. Bendary, Mr R. Gascuena...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

How should I treat my patient with acute heart failure? - Chat Moderator.

27 August 2021

ESC Premium Access

What's next to reduce cardiovascular risk? - Chat Moderator.

27 August 2021

ESC Premium Access

Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

27 August 2021

ESC 365 is supported by

logo Novo Nordisk